{"id":"2dd92afc-8a32-4c63-b5ad-b45fd0afeb88","name":"Nia Therapeutics","slug":"nia-therapeutics","description":"Nia Therapeutics (Nia TX) is a San Francisco-based brain-computer interface company developing an AI-guided brain implant for memory loss. Its [Smart Neurostimulation System (SNS)](/models/nia-smart-neurostimulation-system) uses closed-loop neurostimulation to improve memory in patients with traumatic brain injury and cognitive disorders. FDA Breakthrough Device Designation granted; first device to receive this designation for memory loss. 60-channel wireless AI-enabled platform validated in vivo.","status":null,"founded":null,"hq":"San Francisco, California, USA","hqLat":null,"hqLng":null,"hqGeocodedAt":null,"hqAddress":null,"hqPrecision":null,"website":"https://www.niatx.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[],"keyFacts":[],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:26:46.607Z","updatedAt":"2026-08-08T22:51:46.313Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/nia-therapeutics","url":"https://registry.deploy.report/companies/nia-therapeutics","name":"Nia Therapeutics","description":"Nia Therapeutics (Nia TX) is a San Francisco-based brain-computer interface company developing an AI-guided brain implant for memory loss. Its [Smart Neurostimulation System (SNS)](/models/nia-smart-neurostimulation-system) uses closed-loop neurostimulation to improve memory in patients with traumatic brain injury and cognitive disorders. FDA Breakthrough Device Designation granted; first device to receive this designation for memory loss. 60-channel wireless AI-enabled platform validated in vivo.","identifier":"2dd92afc-8a32-4c63-b5ad-b45fd0afeb88","address":"San Francisco, California, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"claimed-not-verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}